Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

Impact of vancomycin resistance on mortality in neutropenic patients with enterococcal bloodstream infection: a retrospective study.

Cho SY, Lee DG, Choi SM, Kwon JC, Kim SH, Choi JK, Park SH, Park YJ, Choi JH, Yoo JH.

BMC Infect Dis. 2013 Oct 29;13:504. doi: 10.1186/1471-2334-13-504.

2.

Impact of vancomycin resistance on mortality among patients with neutropenia and enterococcal bloodstream infection.

DiazGranados CA, Jernigan JA.

J Infect Dis. 2005 Feb 15;191(4):588-95. Epub 2005 Jan 17.

PMID:
15655783
3.

Enterococcal bacteremia is associated with increased risk of mortality in recipients of allogeneic hematopoietic stem cell transplantation.

Vydra J, Shanley RM, George I, Ustun C, Smith AR, Weisdorf DJ, Young JA.

Clin Infect Dis. 2012 Sep;55(6):764-70. doi: 10.1093/cid/cis550. Epub 2012 Jun 12.

4.

Emergence of vancomycin-resistant Enterococcus bloodstream infections in southern Taiwan.

Chou CH, Lee NY, Lee HC, Chang CM, Lee CC, Ko WC.

J Microbiol Immunol Infect. 2012 Jun;45(3):221-7. doi: 10.1016/j.jmii.2011.11.005. Epub 2012 May 10.

5.

Attributable costs of enterococcal bloodstream infections in a nonsurgical hospital cohort.

Butler AM, Olsen MA, Merz LR, Guth RM, Woeltje KF, Camins BC, Fraser VJ.

Infect Control Hosp Epidemiol. 2010 Jan;31(1):28-35. doi: 10.1086/649020.

6.

A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia.

Bhavnani SM, Drake JA, Forrest A, Deinhart JA, Jones RN, Biedenbach DJ, Ballow CH.

Diagn Microbiol Infect Dis. 2000 Mar;36(3):145-58.

PMID:
10729656
7.

Vancomycin-resistant Enterococcal Bloodstream Infections in Hematopoietic Stem Cell Transplant Recipients and Patients with Hematologic Malignancies: Impact of Daptomycin MICs of 3 to 4 mg/L.

Chong PP, van Duin D, Bangdiwala A, Ivanova A, Miller WC, Weber DJ, Gilligan PH, Shea TC.

Clin Ther. 2016 Nov;38(11):2468-2476. doi: 10.1016/j.clinthera.2016.09.011. Epub 2016 Oct 19.

PMID:
27771176
8.

Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes.

Lucas GM, Lechtzin N, Puryear DW, Yau LL, Flexner CW, Moore RD.

Clin Infect Dis. 1998 May;26(5):1127-33.

PMID:
9597241
9.

Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis.

DiazGranados CA, Zimmer SM, Klein M, Jernigan JA.

Clin Infect Dis. 2005 Aug 1;41(3):327-33. Epub 2005 Jun 28.

PMID:
16007529
10.

Systemic inflammatory response syndrome in adult patients with nosocomial bloodstream infections due to enterococci.

Bar K, Wisplinghoff H, Wenzel RP, Bearman GM, Edmond MB.

BMC Infect Dis. 2006 Sep 26;6:145.

11.

Risk of vancomycin-resistant Enterococcus (VRE) bloodstream infection among patients colonized with VRE.

Olivier CN, Blake RK, Steed LL, Salgado CD.

Infect Control Hosp Epidemiol. 2008 May;29(5):404-9. doi: 10.1086/587647.

PMID:
18419361
12.

Enterococcus faecium bacteremia: does vancomycin resistance make a difference?

Stosor V, Peterson LR, Postelnick M, Noskin GA.

Arch Intern Med. 1998 Mar 9;158(5):522-7.

PMID:
9508230
13.

Evaluation of risk factors for vancomycin-resistant Enterococcus bacteremia among previously colonized hematopoietic stem cell transplant patients.

Kang Y, Vicente M, Parsad S, Brielmeier B, Pisano J, Landon E, Pettit NN.

Transpl Infect Dis. 2013 Oct;15(5):466-73. doi: 10.1111/tid.12120. Epub 2013 Aug 4.

PMID:
23911080
14.

Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections.

Shay DK, Maloney SA, Montecalvo M, Banerjee S, Wormser GP, Arduino MJ, Bland LA, Jarvis WR.

J Infect Dis. 1995 Oct;172(4):993-1000.

PMID:
7561221
15.

Vancomycin-resistant Enterococcus colonization and bloodstream infection: prevalence, risk factors, and the impact on early outcomes after allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia.

Hefazi M, Damlaj M, Alkhateeb HB, Partain DK, Patel R, Razonable RR, Gastineau DA, Al-Kali A, Hashmi SK, Hogan WJ, Litzow MR, Patnaik MM.

Transpl Infect Dis. 2016 Dec;18(6):913-920. doi: 10.1111/tid.12612. Epub 2016 Nov 11.

PMID:
27642723
16.

The risk of developing a vancomycin-resistant Enterococcus bloodstream infection for colonized patients.

Salgado CD.

Am J Infect Control. 2008 Dec;36(10):S175.e5-8. doi: 10.1016/j.ajic.2008.10.010.

PMID:
19084155
17.

Incidence of vancomycin-resistant enterococci (VRE) infection in high-risk febrile neutropenic patients colonized with VRE.

Bossaer JB, Hall PD, Garrett-Mayer E.

Support Care Cancer. 2010 Feb;19(2):231-7. doi: 10.1007/s00520-009-0808-y. Epub 2010 Jan 13.

PMID:
20069435
18.

Enterococcal bacteremia: risk factors for vancomycin resistance and predictors of mortality.

Lautenbach E, Bilker WB, Brennan PJ.

Infect Control Hosp Epidemiol. 1999 May;20(5):318-23.

PMID:
10349947
19.

Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia. a prospective multicenter study.

Vergis EN, Hayden MK, Chow JW, Snydman DR, Zervos MJ, Linden PK, Wagener MM, Schmitt B, Muder RR.

Ann Intern Med. 2001 Oct 2;135(7):484-92.

PMID:
11578151
20.

Vancomycin-resistant enterococcal bloodstream infections on a hematopoietic stem cell transplant unit: are the sick getting sicker?

Dubberke ER, Hollands JM, Georgantopoulos P, Augustin K, DiPersio JF, Mundy LM, Khoury HJ.

Bone Marrow Transplant. 2006 Dec;38(12):813-9. Epub 2006 Oct 23.

PMID:
17057724

Supplemental Content

Support Center